Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: Are large randomized trials still possible?

Journal of Hepatology

Volumn 38, Issue 4, 2003, Pages 518-520

  Poynard, Thierry ^a   Thabut, Dominique ^a   Chryssostalis, Ariane ^a   Taieb, Julien ^a   Ratziu, Vlad ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; C REACTIVE PROTEIN; CORTICOSTEROID; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NORFLOXACIN; PREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ASCITES; BLEEDING; CANDIDA ALBICANS; CANDIDIASIS; CAUSE OF DEATH; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG TOLERABILITY; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFECTION; INFECTION RISK; LIVER BIOPSY; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZATION; REDUCTION; SEPTICEMIA; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TREATMENT INDICATION; TUBERCULOSIS;

ANTIBODIES, MONOCLONAL; GASTROINTESTINAL AGENTS; HEPATITIS, ALCOHOLIC; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037383471     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00045-X     Document Type: Editorial

References (10)

1. Mathurin P, Mendenhall CL, Carithers RL, Ramond MJ, Maddrey WC, Garstide P, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480-487.
2. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-1476.
3. Spahr L, Rubbia-Brandt L, Frossard J, Giostra E, Rougemont A, Pugin J, et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 2002;37:448-456.
4. Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003;38:419-425.
5. Conn HO, Poynard T. Adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 1984;310:201-202.
6. Conn HO, Poynard T. Adrenocorticosteroid administration and peptic ulcer: a critical analysis. J Chronic Dis 1985;38:457-468.
7. Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 1994;236:619-632.
8. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847-1853.
9. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1637-1648.
10. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-1104.